Cellectar Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Cellectar Biosciences, Inc. (CLRB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 27.50 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-04
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-06-30 was -15.89K shares.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-03-31 was 17.99K shares.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-09-30 was 29.17K shares, a 38.96% decline year-over-year.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 27.50K shares, a 142.40% increase from fiscal 2023.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 11.35K shares.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 58.48K shares, a 106.21% increase from fiscal 2015.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2015 was 28.36K shares, a 1562.37% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 98 month |
|---|---|---|---|---|---|---|
| 2024-12-31 | 27.50K shares 10-K · filed 2026-03-04 | 825.10K shares 10-K · filed 2025-03-13 | ||||
| 2023-12-31 | 11.35K shares 10-K · filed 2025-03-13 | |||||
| 2018-06-30 | -15.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 2.10K shares 10-Q · filed 2018-08-10 | ||||
| 2018-03-31 | 17.99K shares 10-Q · filed 2018-05-11 | |||||
| 2017-09-30 | 29.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 29.17K shares derived: sum of 2 quarters · filed 2017-11-09 | 29.17K shares 10-Q · filed 2017-11-09 | 38.10K shares derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 0.00 shares 10-Q · filed 2017-08-14 | 8.93K shares derived: sum of 3 quarters · filed 2017-08-14 | 56.72K shares derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-11 | 8.93K shares derived: sum of 2 quarters · filed 2017-05-11 | 56.72K shares derived: sum of 3 quarters · filed 2017-05-11 | 57.59K shares derived: sum of 4 quarters · filed 2017-05-11 | ||
| 2016-12-31 | 8.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 56.72K shares derived: sum of 2 quarters · filed 2017-03-15 | 57.59K shares derived: sum of 3 quarters · filed 2017-03-15 | 58.48K shares 10-K · filed 2017-03-15 | ||
| 2016-09-30 | 47.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 48.66K shares derived: sum of 2 quarters · filed 2016-11-10 | 49.55K shares 10-Q · filed 2016-11-10 | -205.86K shares derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2016-06-30 | 876.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 1.77K shares 10-Q · filed 2016-08-11 | -253.65K shares derived: sum of 3 quarters · filed 2017-03-15 | 259.60K shares derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2016-03-31 | 890.00 shares 10-Q · filed 2016-05-12 | -254.52K shares derived: sum of 2 quarters · filed 2017-03-15 | 258.73K shares derived: sum of 3 quarters · filed 2017-03-15 | 29.25K shares derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2015-12-31 | -255.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 257.83K shares derived: sum of 2 quarters · filed 2017-03-15 | 28.36K shares derived: sum of 3 quarters · filed 2017-03-15 | 28.36K shares 10-K · filed 2017-03-15 | 28.38K shares 10-K · filed 2016-03-11 | |
| 2015-09-30 | 513.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 283.77K shares derived: sum of 2 quarters · filed 2015-11-12 | 283.77K shares 10-Q · filed 2015-11-12 | 271.00K shares derived: sum of 4 quarters · filed 2016-10-20 | ||
| 2015-06-30 | -229.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -229.47K shares 10-Q · filed 2015-08-12 | -242.24K shares derived: sum of 3 quarters · filed 2016-10-20 | -242.24K shares derived: sum of 4 quarters · filed 2016-10-20 | ||
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-20 | -12.77K shares derived: sum of 2 quarters · filed 2016-10-20 | -12.77K shares derived: sum of 3 quarters · filed 2016-10-20 | -287.77K shares derived: sum of 4 quarters · filed 2016-10-20 | ||
| 2014-12-31 | -12.77K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-10-20 | -12.77K shares derived: sum of 2 quarters · filed 2016-10-20 | -287.77K shares derived: sum of 3 quarters · filed 2016-10-20 | 1.71K shares 10-K/A · filed 2016-10-20 | 17.05K shares 10-K · filed 2015-03-24 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-20 | -275.00K shares derived: sum of 2 quarters · filed 2015-05-20 | 14.47K shares 10-Q · filed 2015-05-20 | -301.79K shares derived: sum of 4 quarters · filed 2015-05-20 | ||
| 2014-06-30 | -275.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | 14.47K shares 10-Q · filed 2014-08-04 | -301.79K shares derived: sum of 3 quarters · filed 2015-05-20 | |||
| 2014-03-31 | 289.47K shares 10-Q · filed 2014-05-14 | -26.79K shares derived: sum of 2 quarters · filed 2015-05-20 | ||||
| 2013-12-31 | -316.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | 22.13K shares 10-K · filed 2015-05-20 | 442.56K shares 10-K · filed 2014-03-19 | |||
| 2013-09-30 | 338.39K shares 10-Q · filed 2013-11-13 | |||||
| 2013-06-30 | 0.00 shares 10-Q · filed 2013-08-12 | 167.55K shares derived: sum of 2 quarters · filed 2013-08-12 | ||||
| 2013-03-31 | 167.55K shares 10-Q · filed 2013-08-12 | |||||
| 2012-12-31 | 343.43K shares 10-K · filed 2014-03-19 | |||||
| 2012-09-30 | -175.88K shares 10-Q · filed 2012-11-06 | -175.88K shares derived: sum of 2 quarters · filed 2012-11-06 | -175.88K shares derived: sum of 3 quarters · filed 2012-11-06 | |||
| 2012-06-30 | 0.00 shares 10-Q · filed 2012-08-09 | 0.00 shares derived: sum of 2 quarters · filed 2012-08-09 | ||||
| 2012-03-31 | 0.00 shares 10-Q · filed 2012-08-09 | |||||
| 2011-12-31 | 459.88K shares 10-K · filed 2014-03-19 | 438.03K shares 10-K · filed 2013-03-28 | ||||
| 2010-12-31 | 21.85K shares 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |